Revealing a Pre-neoplastic Renal Tubular Lesion by p-S6 Protein Immunohistochemistry after Rat Exposure to Aristolochic Acid

Main Article Content

Alexandra Gruia
Patrycja Gazinska
Diana Herman
Valentin Ordodi
Calin Tatu
Peter Mantle

Keywords

Aristolochic acid, Balkan nephropathy, Ochratoxin A, Ribosomal phospho-S6 protein, Urothelial tumours

Abstract

Aristolochic acid (AA) has, in the last decade, become widely promoted as the cause of the Balkan endemic nephropathy and associated renal or urothelial tumours, although without substantial focal evidence of the quantitative dietary exposure via bread in specific households in hyperendemic villages. Occasional ethnobotanical use of Aristolochia clematitis might be a source of AA, and Pliocene lignite contamination of well-water is also a putative health risk factor. The aim of this study was two-fold: to verify if extracts of A. clematitis and Pliocene, or AA by itself, could induce the development of renal or urothelial tumours, and to test the utility of the ribosomal protein p-S6 to identify preneoplastic transformation. Rats were given extracts of A. clematitis in drinking water or AA I, by gavage.  After seven months, renal morphology was studied using conventional haematoxylin and eosin and immunohistochemistry for ribosomal p-S6 protein.  Plant extracts (cumulative AA approximately 1.8 g/kg b.w.) were tolerated and caused no gross pathology or renal histopathological change, with only faint diffuse p-S6 protein (except in the papilla) as in controls. Cumulative AA I (150 mg/kg b.w. given over 3 days) was also tolerated for seven months by all recipients, without gross pathology or kidney tumours. However, p-S6 protein over-expression was consistent particularly within the renal papilla. In one case given AA I, intense p-S6 protein staining of a proximal tubule fragment crucially matched the pre-neoplastic histology in an adjacent kidney section.  We briefly discuss these findings, which compound uncertainty concerning the cause of the renal or upper urinary tract tumours of the Balkan endemic nephropathy.

Abstract 3270 | PDF Downloads 961 HTML Downloads 2243

References

1. Krogh P. Causal associations of mycotoxic nephropathy. Acta Pathol Microbiol Scand Sect A Suppl. 1978;269:1-28.
2. Ivic M. The problem of aetiology of endemic nephropathy. Acta Facultatis Medicae Naissensis. 1970;1:29-38.
3. NTP. Report on carcinogens; background document for aristolochic acid. 2008 (http://ntp.niehs.nih.gov/files/aristolochic_acids_(final-02sep08)_redo2%5B3%5D.pdf
4. Mengs U, Lang W, Poch JA. The carcinogenic action of aristolochic acid in rats. Arch Toxicol. 1982;51:107-119.
http://dx.doi.org/10.1007/BF00302751
5. Mengs U. On the histopathogenesis of rat forestomach carcinoma caused by aristolochic acid. Arch Toxicol. 1983;52:209-220. http://dx.doi.org/10.1007/BF00333900 PMid:6860143
6. Orem WH, Tatu CA, Lerch HE, Maharaj SVM, Pavlovic N, Paunescu V, Dumitrascu V. Identification and environmental significance of the organic compounds in water supplies associated with a Balkan endemic nephropathy region in Romania. J Environ Health Res. 2004;3:53-61.
7. Cosyns JP, Dehoux JP, Guiot Y, Goebbels R-M, Robert A, Bernard AM, van Ypersele de Strihou C. Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy? Kidney Int. 2001;59:2164-2173. http://dx.doi.org/10.1046/j.1523-1755.2001.00731.x PMid:11380818
8. Cui M, Liu Z-H, Qiu Q, Li H, Li L-S. Tumour induction in rats following exposure to short-term high dose aristolochic acid 1. Mutagenesis. 2005;20:45-49. http://dx.doi.org/10.1093/mutage/gei007 PMid:15644423
9. Mantle P, Modalca M, Nicholls A, Tatu C, Tatu D, Toncheva D. Comparative 1H NMR metabolomic urinalysis of people diagnosed with Balkan endemic nephropathy, and healthy subjects, in Romania and Bulgaria: a pilot study. Toxins. 2011;3:815-833. http://dx.doi.org/10.3390/toxins3070815 PMid:22069742 PMCid:PMC3202861
10. Gazinska P, Herman D, Gillett C, Pinder S, Mantle, P. Comparative immunohistochemical analysis of ochratoxin A tumourigenesis in rats and urinary tract carcinoma in humans; mechanistic significance of p-S6 ribosomal protein expression. Toxins. 2012;4:643-662. http://dx.doi.org/10.3390/toxins4090643 PMid:23105973 PMCid:PMC3475221
11. Stemmer K, Ellinger-Ziegelbauer H, Ahr HJ, Dietrich DR. Carcinogen-specific gene expression profiles in short term treated Eker and wild-type rats indicative of pathways involved in renal tumourigenesis. Cancer Res. 2007;67:4052-4068. http://dx.doi.org/10.1158/0008-5472.CAN-06-3587 PMid:17483316
12. Debelle F, Nortier J, Arlt VM, De Prez E, Vienne A, Salmon I, Phillips DH, Deschodt-Lanckman M, Vanherweghem J L. Effects of dexfenfluramine on aristolochic acid nephrotoxicity in a rat model for Chinese-herb nephropathy. Arch Toxicol. 2003;77:218-226. PMid:12698237
13. Hasumi Y, Baba M, Ajima R, Hasumi H, Valera VA, Klein ME, Haines DC, Merino MJ, Hong S-B, Yamaguchi TP et al. Homozygous loss of BDH causes erarly embryonic lethality and kidney tumor development with activation of m TORC1 and mTORC2. Proc Natl Acad Sci USA 2009;106:18722-18727. http://dx.doi.org/10.1073/pnas.0908853106 PMid:19850877 PMCid:PMC2765925
14. McDorman KS, Wolf DC. Use of the spontaneous knockout (Eker) rat model of hereditary renal cell carcinoma for the study of renal carcinogens. Toxicol Pathol. 2002;30:675-680. http://dx.doi.org/10.1080/01926230290168542
15. Wilson C, Bonnet C, Guy C, Idziaszczyk S, Colley J, Humphrys V, Maynard J, Sampson, JR, Cheadle JP. Tsc1 haploinsufficiency without mammalian target of rapamycin activation is sufficient for renal cyst formation in Tsc1+/- mice. Cancer Res. 2006;66:7934-7938. http://dx.doi.org/10.1158/0008-5472.CAN-06-1740 PMid:16912167
16. U.S. EPA. Recommendations for and documentation of values for use in risk assessment. EPA/600/6-87/008.
17. Anon. 1988. Rat/mouse default values. http://www.tera.org/Tools/ratmousevalues.pdf.
18. Schmeiser HH, Janssen JW, Lyons J, Scherf HR, Pfau W, Buchmann A, Wiessler M. Aristolochic acid activates ras genes in rat tumours at deoxyadenosine residues. Cancer Res. 1990;50:5464-5469. PMid:2201437
19. Michl J, Ingrouille MJ, Simmonds MSJ, Heinrich M. Naturally occurring aristolochic acid analogues and their toxicities. Nat Prod Rep. 2014;31:676-693. http://dx.doi.org/10.1039/c3np70114j PMid:24691743
20. Mantle P, Kulinskaya E, Nestler S. Renal tumourigenesis in male rats in response to chronic dietary ochratoxin A. Food Add Contam Supple 1. 2005:58-64. http://dx.doi.org/10.1080/02652030500358431 PMid:16332623
21. Boorman GA. Toxicology and carcinogenesis studies of ochratoxin A. NIH Publication No 89-2813 Research Triangle Park, NC, National Toxicology Programme, 1989.
22. http://tpx.sagepub.com/content/35/4/589/F6.expansion.html
23. Koch R. "Untersuchungen uber Bakterien: V. Die Atiologie der Milzbrand-Krankheit, begrundet auf die Entwicklungsgeschichte des Bacillus anthracis" [Investigations into bacteria: V. The etiology of anthrax, based on the ontogenesis of Bacillus anthracis]. Cohns Beitrage zur Biologie der Pflanzen 1876;2:277–310.[In german]
24. Hill AB. The environment and disease: association and causation? J R Soc Med. 2015;108:32-37. http://dx.doi.org/10.1177/0141076814562718 PMid:25572993
25. Wakeford R. Association and causation in epidemiology - half a century since the publication of Bradford Hill's interpretational guidance. J R Soc Med. 2015;108:4-6. http://dx.doi.org/10.1177/0141076814562713 PMid:25572986
26. Hranjec T, Kovac A, Kos J, Mao W, Chen JJ, Grollman AP, Jelakovic B. Endemic nephropathy: the case for chronic poisoning by Aristolochia. Croat Med J. 2005;46:116-125. 28, De Broe ME. Chinese herbs nephropathy and Balkan endemic nephropathy: towards a single entity, aristolochic acid nephropathy. Kidney Int. 2012;80:513-515.
27. Pepeljnjiak S, Klaric MS. Suspects in etiology of endemic nephropathy: aristolochic acid versus mycotoxins. Toxins. 2010;2:1414-1427. http://dx.doi.org/10.3390/toxins2061414 PMid:22069645 PMCid:PMC3153240
28. De Broe ME. Chinese herbs nephropathy and Balkan endemic nephropathy: towards a single entity, aristolochic acid nephropathy. Kidney Int. 2012;80:513-515. http://dx.doi.org/10.1038/ki.2011.428 PMid:22373701
29. Jelakovic B et al. Aristolactam-DNA adducts in the renal cortex: biomarker of environmental exposure to aristolochic acid. Kidney Int. 2012;81:559-567. http://dx.doi.org/10.1038/ki.2011.371 PMid:22071594 PMCid:PMC3560912
30. Jelakovic B et al. Concensus statement on screening, diagnosis, classification and treatment of endemic (Balkan) nephropathy. Nephrol Dial Transplant. 2013. PMid:24166461